Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (441-450 of 525) with videos related to

Pageof 53
Sort By:
Journal of the American Chemical Society|January 8, 2013
Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expressionAmnon Bar-Shir, Guanshu Liu, Yajie Liang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical TherapyAna P Kiess, Il Minn, Ganesan Vaidyanathan, et al.
Nuclear Medicine and Biology|May 18, 2013
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptorHayden T Ravert, Peter Dorff, Catherine A Foss, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 10, 2018
Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathyHulya Yalcin, Ines Valenta, Min Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2014
18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PETAndrew G Horti, Yongjun Gao, Hiroto Kuwabara, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
EJNMMI Research|December 29, 2022
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PETKevin H Leung, Steven P Rowe, Jeffrey P Leal, et al.
Translational Psychiatry|April 13, 2016
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasmaJ M Coughlin, Y Wang, E B Ambinder, et al.
Npj Imaging|August 1, 2025
Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRIYuki Hodo, Caitlin M Tressler, Behnaz Ghaemi, et al.
Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.
Pageof 53

Showing results (441-450 of 525) with videos related to

Sort By:
Pageof 53
Journal of the American Chemical Society|January 8, 2013
Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expressionAmnon Bar-Shir, Guanshu Liu, Yajie Liang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical TherapyAna P Kiess, Il Minn, Ganesan Vaidyanathan, et al.
Nuclear Medicine and Biology|May 18, 2013
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptorHayden T Ravert, Peter Dorff, Catherine A Foss, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 10, 2018
Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathyHulya Yalcin, Ines Valenta, Min Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2014
18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PETAndrew G Horti, Yongjun Gao, Hiroto Kuwabara, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
EJNMMI Research|December 29, 2022
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PETKevin H Leung, Steven P Rowe, Jeffrey P Leal, et al.
Translational Psychiatry|April 13, 2016
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasmaJ M Coughlin, Y Wang, E B Ambinder, et al.
Npj Imaging|August 1, 2025
Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRIYuki Hodo, Caitlin M Tressler, Behnaz Ghaemi, et al.
Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.
Pageof 53